PK PD models

Results: 12



#Item
1Announcing a Post-ACoP7 workshop presented by  Simulation from ODE-based population PK/PD and systems pharmacology models in R using mrgsolve  Register today at www.acop7.org

Announcing a Post-ACoP7 workshop presented by Simulation from ODE-based population PK/PD and systems pharmacology models in R using mrgsolve Register today at www.acop7.org

Add to Reading List

Source URL: metrumrg.com

Language: English - Date: 2016-03-23 12:41:22
    2Source-to-Outcome Modeling Physiologically Based Pharmacokinetic/Pharmacodynamic (PBPK/PD) Model Linked to a Dietary Exposure Model: Chlorpyrifos as a Case Study Science Issues Paper for SAP Meeting on Chlorpyrifos Physi

    Source-to-Outcome Modeling Physiologically Based Pharmacokinetic/Pharmacodynamic (PBPK/PD) Model Linked to a Dietary Exposure Model: Chlorpyrifos as a Case Study Science Issues Paper for SAP Meeting on Chlorpyrifos Physi

    Add to Reading List

    Source URL: allianceforrisk.org

    Language: English - Date: 2014-02-13 19:55:39
    3

    PDF Document

    Add to Reading List

    Source URL: www.statsoc.org.au

    Language: English - Date: 2014-03-27 21:10:27
    4Exposure Response in Drug Development

    Exposure Response in Drug Development

    Add to Reading List

    Source URL: www.anoixiscorp.com

    Language: English - Date: 2008-03-20 16:49:49
    5An Introduction to Nonlinear Mixed Effects Models and PK/PD Analysis Marie Davidian Department of Statistics North Carolina State University

    An Introduction to Nonlinear Mixed Effects Models and PK/PD Analysis Marie Davidian Department of Statistics North Carolina State University

    Add to Reading List

    Source URL: www4.stat.ncsu.edu

    Language: English - Date: 2010-04-30 12:26:14
    6Microsoft PowerPoint - ReydermanACoP2009 [Read-Only] [Compatibility Mode]

    Microsoft PowerPoint - ReydermanACoP2009 [Read-Only] [Compatibility Mode]

    Add to Reading List

    Source URL: www.accp1.org

    Language: English - Date: 2011-03-25 17:45:46
    7Description of the Particular Matter to Which the Waiver Applies: The committee will discuss the clinical pharmacology aspects of pediatric clinical trial design and dosing to optimize pediatric drug development. FDA wi

    Description of the Particular Matter to Which the Waiver Applies: The committee will discuss the clinical pharmacology aspects of pediatric clinical trial design and dosing to optimize pediatric drug development. FDA wi

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    8Alan Forrest, Pharm.D. Institute for Clinical Pharmacodynamics 43 British American Blvd. Latham, NY[removed]Telephone: ([removed]E-mail: [removed]

    Alan Forrest, Pharm.D. Institute for Clinical Pharmacodynamics 43 British American Blvd. Latham, NY[removed]Telephone: ([removed]E-mail: [removed]

    Add to Reading List

    Source URL: cellceutix.com

    Language: English - Date: 2014-01-15 02:02:06
    9Northeastern Illinois Chapter of the American Statistical Association Volume 16, Issue 3 FALL, 2001

    Northeastern Illinois Chapter of the American Statistical Association Volume 16, Issue 3 FALL, 2001

    Add to Reading List

    Source URL: www.amstat.org

    Language: English - Date: 2011-03-11 10:55:22
    10Physiologically-Based Pharmacokinetic/Pharmacodynamic Modeling: Preliminary Evaluation and Case study for the N-Methyl Carbamate Pesticides

    Physiologically-Based Pharmacokinetic/Pharmacodynamic Modeling: Preliminary Evaluation and Case study for the N-Methyl Carbamate Pesticides

    Add to Reading List

    Source URL: www.epa.gov

    Language: English - Date: 2008-01-31 14:05:45